Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tel-Aviv Sourasky Medical Center | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
decipher the role of microbiota in glycemic response change after bariatric surgery
Despite the vast knowledge linking the gut microbiome to metabolism and the glucose response, the relation still remains unclear. hopefully, a deep understanding of the mechanisms underlying metabolic improvement following bariatric surgery will make it possible to identify targets for pharmacological intervention, which will reduce the need for surgery and its risks.
Previous studies have characterized the microbiome after bariatric surgery, but most suffer from methodological limitations.
The current study has the potential to be innovative and make a significant contribution to understanding the mechanisms involved in early metabolic improvement after bariatric surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| sleeve gastrectomy surgery | participants undergoing sleeve gastrectomy surgery for weight reduction |
| |
| gastric bypass surgery | participants undergoing gastric bypass surgery for weight reduction |
| |
| cholecystectomy | participants undergoing cholecystectomy |
| |
| Pancreatectomy | participants undergoing Pancreatectomy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sleeve gastrectomy surgery | Procedure | participants undergoing sleeve gastrectomy surgery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Glycemic response | The glycemic response will be measured by taking a blood test (glucose) after 12 hours fast and a second blood test (glucose) after an OGTT(oral glucose tolerance test) of 50 g glucose | up to 4 years |
| microbiota composition | The microbiota composition will be assessed using the stool samples of the participants. | up to 4 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
patients arriving at the outpatient unit at Tel Aviv Sourasky medical center
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Avner Leshem, MD | Contact | +972547487555 | avner.leshem@weizmann.ac.il |
| Name | Affiliation | Role |
|---|---|---|
| Avner Leshem, MD | Weizmann institute | Study Director |
| Danit Dayan, MD | Souraski medical center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Weizmann Institute of Science | Recruiting | Rehovot | Israel |
Not provided
| ID | Term |
|---|---|
| D010180 | Pancreatectomy |
| ID | Term |
|---|---|
| D013505 | Digestive System Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
stool, serum
| gastric bypass surgery | Procedure | participants undergoing gastric bypass surgery |
|
| control | Procedure | cholecystectomy |
|
| Pancreatectomy | Procedure | Collecting a sample of an unidentified healthy pancreas to extract insulin-secreting beta cells from the sample |
|
| Souraski medical center | Recruiting | Tel Aviv | Israel |
|